Empresa Fluoropharma Medical Inc OTC Bulletin Board
Acciones
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 16/05/22 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/05/22 |
Chairman | 78 | 14/02/11 | |
Edward L. Lyons
PRN | Corporate Officer/Principal | - | 28/10/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 78 | 14/02/11 | |
William Lewis
BRD | Director/Board Member | 48 | 06/11/15 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 16/05/22 |
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 16/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 5 382 071 | 0 | 0 | 99,97 % |
Acción B | 1 | 34 262 264 | 34 262 264 ( 100,00 %) | 0 | |
Acción C | 0 | 9 370 | 0 | 0 |
Información de la empresa
FluoroPharma Medical, Inc.
701 South Carson Street Suite 200
89701, Carson City
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 44,96 mil M | |
+48,77 % | 41,85 mil M | |
+1,17 % | 42,65 mil M | |
-4,27 % | 29,04 mil M | |
+11,42 % | 26,08 mil M | |
-21,39 % | 19,03 mil M | |
+4,86 % | 12,75 mil M | |
+27,29 % | 12,06 mil M | |
-3,50 % | 11,75 mil M |